Medicine in Australia could soon become more expensive and harder to come by. The Pharmaceutical Benefits Scheme – the safety net that keeps our prescriptions cheap – has been drawn into Donald Trump’s trade war, after the US president signed an order saying the United States should not pay more for medicines than its peer countries. Drug companies have now paused new PBS listings and warn some treatments may never reach Australian patients. Today, special correspondent for The Saturday Paper, Jason Koutsoukis, on how one decision in Washington could force Australians to pay more for vital drugs – and whether Canberra has the leverage to stop it. If you enjoy 7am, the best way you can support us is by making a contribution at 7ampodcast.com.au/support. Socials: Stay in touch with us on Instagram Guest: Special correspondent for The Saturday Paper, Jason Koutsoukis. Photo: AP Photo/Julio CortezSee omnystudio.com/listener for privacy information.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare
The method of invention, AI's new clock speed and why capital markets are confused
05 Dec 2025
Azeem Azhar's Exponential View
Meta Stock Surges on Plans for Metaverse Cuts
05 Dec 2025
Bloomberg Tech